Vimarsana
Biggest News Aggregation in the World

Page 2 - Markh Drazner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Markh Drazner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Markh Drazner Today - Breaking & Trending Today

Dapagliflozin Early Benefit Explored in Reduced-EF Heart Failure - Vimarsana News

Dapagliflozin Early Benefit Explored in Reduced-EF Heart Failure

Published: June 7, 2022

Why have SGLT2-inhibitor clinical benefits in HFrEF trials been evident so soon after the drugs are started? Recent studies shed light on one potential mechanism among what are probably many.

Source: medscape.com
Related Topics:
Glasgow CityUnited KingdomUnited StatesUniversity Of Texas Southwestern Medical CenterVifor PharmaKieranf DochertyMarkh DraznerEli LillyInstitute Of CardiovascularBoehringer IngelheimUniversity Of GlasgowUniversity Of ValenciaHeart Failure AssociationEuropean SocietyEuropean JournalHeart FailureTexas Southwestern Medical CenterMedical SciencesFailure AssociationLate Breaking TrialsRandomized ClinicalPresented May
Flu Vaccines Cut Seasonal Death in Patients With Heart Failure - Vimarsana News

Flu Vaccines Cut Seasonal Death in Patients With Heart Failure

Published: April 5, 2022

Annual influenza vaccines significantly cut death during serial flu seasons in patients with heart failure in the prospective, placebo-controlled IVVE trial.

Source: medscape.com
Related Topics:
University Of Texas Southwestern Medical CenterUnited StatesMarkh DraznerMark LoebMcmaster UniversityBaptist Health In PaducahYork Heart AssociationAmerican College Of CardiologyAmerican CollegeEvidence SupportsTexas Southwestern Medical CenterCraig BeaversBaptist HealthNew York Heart Association